Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literature.
Paul de LaatNienke van EngelenJack F WetzelsJan A M SmeitinkMirian C H JanssenPublished in: Clinical kidney journal (2019)
Renal involvement in carriers of the m.3243A>G mutation most commonly leads to proteinuria and FSGS and may lead to ESRD. Proper recognition of the mitochondrial origin of the renal disease in these patients is important for adequate treatment selection and suitable supportive care. This case series and review of the available literature on long-term follow-up after kidney transplantation shows it is feasible for non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype carriers of the m.3243A>G mutation to be considered for kidney transplantation in case of ESRD. These patients should not be excluded from transplant solely for their mitochondrial diagnosis.
Keyphrases
- end stage renal disease
- chronic kidney disease
- oxidative stress
- peritoneal dialysis
- newly diagnosed
- kidney transplantation
- ejection fraction
- atrial fibrillation
- prognostic factors
- systematic review
- palliative care
- early onset
- pain management
- duchenne muscular dystrophy
- cerebral ischemia
- patient reported
- replacement therapy